- Home
- KIDS vs CYRX Comparison
KIDS vs CYRX Comparison
Compare KIDS & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIDS | CYRX |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.9M | 472.7M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | KIDS | CYRX |
|---|---|---|
| Price | $16.86 | $9.44 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $24.56 | $12.83 |
| AVG Volume (30 Days) | 152.5K | ★ 357.3K |
| Earning Date | 03-03-2026 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.27 |
| Revenue | $227,410,000.00 | ★ $243,795,000.00 |
| Revenue This Year | $16.72 | N/A |
| Revenue Next Year | $12.35 | $9.12 |
| P/E Ratio | ★ N/A | $7.60 |
| Revenue Growth | 19.90 | ★ 41.27 |
| 52 Week Low | $15.28 | $4.58 |
| 52 Week High | $26.40 | $11.45 |
Technical Indicators
Market Signals| Indicator | KIDS | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.74 | 38.80 |
| Support Level | $17.00 | $9.31 |
| Resistance Level | $17.78 | $10.39 |
| Average True Range (ATR) | 0.79 | 0.51 |
| MACD | -0.18 | -0.19 |
| Stochastic Oscillator | 9.77 | 13.52 |
Price Performance
Historical ComparisonAbout KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.